Cancer diagnostics company, Pacific Edge, has announced that it will release its half-year results for the six months ending Sept 30, 2024, on Nov 26, 2024.
The results will be made available prior to 10am, followed by an investor and analyst conference call at 11am.
The conference call will be accessible via webcast and phone.
Pacific Edge, headquartered in Dunedin, specialises in the development and commercialisation of bladder cancer diagnostic and prognostic tests.
Its Cxbladder tests are offered globally through its laboratories in New Zealand and the USA.
See more
